It provides a base on which the amino acid chain can grow
2013;98:E66471
Subcutaneous injection delivers approximately 100% of the administered dose into systemic circulation
Provider review: A licensed clinician determines if GLP-1 medication is appropriate, usually within 24-48 hours
Common GLP-1 Side Effects Commonly reported semaglutide side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain Reduced appetite Bloating or fullness Indigestion Dizziness Fatigue Symptoms, Possible Concerns, and Related Tests Safety note: Severe abdominal pain, inability to keep fluids down, very low urine output, jaundice, facial or throat swelling, difficulty breathing, confusion, or sudden vision changes should not wait for routine outpatient lab testing
Wegovy is approved for chronic weight management in eligible patients, while Ozempic is approved for type 2 diabetes